What Researchers Did
Researchers conducted a review of existing literature to examine the association between warfarin use and valvular and vascular calcification.
What They Found
The review found that warfarin, by inhibiting vitamin K-dependent γ-carboxylation of matrix Gla protein, is associated with valvular and vascular calcification in various animal and human studies. While no specific guidelines exist, discontinuing warfarin and using alternative anticoagulants like dabigatran or rivaroxaban is considered a reasonable option, with other drugs like statins and vitamin K also under investigation.
What This Means for Canadian Patients
Canadian patients currently taking warfarin should discuss the potential risk of valvular and vascular calcification with their healthcare providers. Exploring alternative anticoagulants or emerging therapies may be beneficial for those at risk or experiencing this side effect.
Canadian Relevance
This review does not have a specific Canadian connection.
Study Limitations
The abstract does not explicitly state the limitations of this review, but the lack of specific guidelines for preventing or treating warfarin-associated calcification suggests an ongoing need for further research.